Security · CUSIP 89422GAB3
TRAVERE THERAPEUTICS INC
NOTE 0.500% 5/1 · institutional ownership from 13F filings
Q3 2026 is still being filed (deadline 45 days after quarter end), so holder counts are incomplete.
13F holders
4
Shares held
1.2M
Value held
$1.4M
New / sold out
2 / 0
Added / reduced
1 / 0
net +914.0K shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q3 2026
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of New York Mellon Corp | 1,150,000 | $1.4M | 0.00% |
| CHOREO, LLC | 13,000 | $15.2K | 0.00% |
| FIFTH THIRD BANCORP | 9,000 | $10.5K | 0.00% |
| FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. | 5,000 | $5.9K | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Bank of New York Mellon Corp | Added | +900,000 | +360.0% |
| FIFTH THIRD BANCORP | New | +9,000 | – |
| FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. | New | +5,000 | – |
Biggest sellers
Nothing to show.